Additionally, SIRT1 inhibits alcohol-mediated inflammation through the NF-B pathway and decreases the expression of fibroblast markers, thereby alleviating liver fibrosis (Liu et al., 2022)
Although several studies suggest its therapeutic potential, additional evidence is needed to confirm its effectiveness in humans, optimise its clinical application, including dosage, duration and grade of hydrolysation, and unveil the mechanisms of action
Participants on the highest dose (15 mg) achieved an average weight reduction of 22.9% over three years, marking one of the longest documented sustained weight loss effects in obesity pharmacotherapy
Cohort studies show slightly less long-term weight gain with higher caffeine intake, but the effect is very small (less than 1.1 lbs over 12 years)
Abstract Postprandial hypoglycemia (PPH) is a challenging and significant complication that can occur following bariatric and metabolic surgery